Skip to search formSkip to main contentSkip to account menu

Bradykinin Receptor Antagonists

Known as: Receptor Blockers, Bradykinin, Bradykinin Antagonists, Antagonists, Bradykinin Receptor 
Compounds and drugs that inhibit ligand binding or cellular signaling by BRADYKININ RECEPTORS.
National Institutes of Health

Related topics

Related topics

19 relations

Narrower (14)

B 9430B 9858CP 0597FR 165649
Bradykinin Receptor Antagonists [MoA]In Bloodaspects of radiation effectschemical synthesis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
New topics in bradykinin research
To cite this article: Maurer M, Bader M, Bas M, Bossi F, Cicardi M, Cugno M, Howarth P, Kaplan A, Kojda G, Leeb‐Lundberg F, L… 
Review
2007
Review
2007
Neuroprotection in traumatic brain injury: a complex struggle against the biology of nature
  • J. Schouten
  • Current Opinion in Critical Care
  • 2007
  • Corpus ID: 20678419
Purpose of reviewTranslating the efficacy of neuroprotective agents in experimental traumatic brain injury to clinical benefit… 
Highly Cited
2007
Highly Cited
2007
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
To explore the role of the kallikrein–kinin system in relation to ischemia/reperfusion injury in the kidney, we generated mice… 
Review
2003
Review
2003
Topical and Peripherally Acting Analgesics
  • J. Sawynok
  • Pharmacological Reviews
  • 2003
  • Corpus ID: 362201
Acute nociceptive, inflammatory, and neuropathic pain all depend to some degree on the peripheral activation of primary sensory… 
Highly Cited
2002
Highly Cited
2002
Signaling Microdomains Define the Specificity of Receptor-Mediated InsP3 Pathways in Neurons
Highly Cited
2000
Highly Cited
2000
Bradyzide, a potent non‐peptide B2 bradykinin receptor antagonist with long‐lasting oral activity in animal models of inflammatory hyperalgesia
Bradyzide is from a novel class of rodent‐selective non‐peptide B2 bradykinin antagonists (1‐(2‐Nitrophenyl)thiosemicarbazides… 
Highly Cited
1998
Highly Cited
1998
Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor, and a nitric oxide scavenger.
The mechanism of the enhanced vascular permeability and retention (EPR) effect seen in solid tumors was investigated with sarcoma… 
Highly Cited
1991
Highly Cited
1991
New, long‐acting, potent bradykinin antagonists
1 Three new bradykinin (BK) antagonists, d‐Arg0‐Hyp3‐Thi5‐d‐Tic7‐Oic8‐BK (compound I), d‐Arg0‐Hyp3‐d‐Tic7‐Oic8‐BK (compound II… 
Highly Cited
1988
Highly Cited
1988
Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions.
Autoradiographic studies localize [3H]bradykinin receptor binding sites to the substantia gelatinosa, dorsal root, and a subset… 
Highly Cited
1988
Highly Cited
1988
Structure and chromosomal localization of the human renal kallikrein gene.
Glandular kallikreins are a family of proteases encoded by a variable number of genes in different mammalian species. In all… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)